Baker McKenzie advises Carnegie Investment Bank and ABG Sundal Collier on stockmarket listing of BONESUPPORT
Trading of shares in BONESUPPORT HOLDINGS on Nasdaq Stockholm commenced today.
BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT™, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months. The products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
Carnegie Investment Bank and ABG Sundal Collier are Joint Global Coordinators and Joint Bookrunners in conjunction with the listing. Baker McKenzie is legal advisor to Carnegie Investment Bank and ABG Sundal Collier. The main participant from Baker McKenzie was Joakim Falkner assisted by Henric Roth and Stefan Balazs (Stockholm), Ross MacDonald (New York) and Edward Bibko and Charles Farnsworth (London).